Logo image of BNGO

BIONANO GENOMICS INC (BNGO) Stock Overview

USA - NASDAQ:BNGO - US09075F4046 - Common Stock

3.88 USD
-0.18 (-4.43%)
Last: 9/12/2025, 8:00:01 PM
3.94 USD
+0.06 (+1.55%)
After Hours: 9/12/2025, 8:00:01 PM

BNGO Key Statistics, Chart & Performance

Key Statistics
52 Week High30.52
52 Week Low2.68
Market Cap18.16M
Shares4.68M
Float4.68M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-42.97
PEN/A
Fwd PEN/A
Earnings (Next)11-11 2025-11-11/amc
IPO08-01 2018-08-01
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


BNGO short term performance overview.The bars show the price performance of BNGO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15 20

BNGO long term performance overview.The bars show the price performance of BNGO in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of BNGO is 3.88 USD. In the past month the price increased by 20.87%. In the past year, price decreased by -84.97%.

BIONANO GENOMICS INC / BNGO Daily stock chart

BNGO Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 21.9 181.05B
DHR DANAHER CORP 25.24 136.09B
A AGILENT TECHNOLOGIES INC 22.61 35.01B
IQV IQVIA HOLDINGS INC 16.32 31.83B
MTD METTLER-TOLEDO INTERNATIONAL 30.8 25.95B
WST WEST PHARMACEUTICAL SERVICES 36.42 18.23B
WAT WATERS CORP 24.15 17.58B
TEM TEMPUS AI INC N/A 15.01B
ILMN ILLUMINA INC 22.87 14.62B
MEDP MEDPACE HOLDINGS INC 36.48 13.78B
ICLR ICON PLC 13.23 13.61B
QGEN QIAGEN N.V. 19.27 9.82B

About BNGO

Company Profile

BNGO logo image Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The company is headquartered in San Diego, California and currently employs 98 full-time employees. The company went IPO on 2018-08-01. The firm offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. The company also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The firm additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The firm markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Company Info

BIONANO GENOMICS INC

9540 Towne Centre Drive, Suite 100

San Diego CALIFORNIA 92121 US

CEO: R. Erik Holmlin

Employees: 99

BNGO Company Website

BNGO Investor Relations

Phone: 18588887600

BIONANO GENOMICS INC / BNGO FAQ

What is the stock price of BIONANO GENOMICS INC today?

The current stock price of BNGO is 3.88 USD. The price decreased by -4.43% in the last trading session.


What is the ticker symbol for BIONANO GENOMICS INC stock?

The exchange symbol of BIONANO GENOMICS INC is BNGO and it is listed on the Nasdaq exchange.


On which exchange is BNGO stock listed?

BNGO stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for BIONANO GENOMICS INC stock?

9 analysts have analysed BNGO and the average price target is 9.69 USD. This implies a price increase of 149.74% is expected in the next year compared to the current price of 3.88. Check the BIONANO GENOMICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BIONANO GENOMICS INC worth?

BIONANO GENOMICS INC (BNGO) has a market capitalization of 18.16M USD. This makes BNGO a Nano Cap stock.


How many employees does BIONANO GENOMICS INC have?

BIONANO GENOMICS INC (BNGO) currently has 99 employees.


What are the support and resistance levels for BIONANO GENOMICS INC (BNGO) stock?

BIONANO GENOMICS INC (BNGO) has a support level at 3.67 and a resistance level at 3.88. Check the full technical report for a detailed analysis of BNGO support and resistance levels.


Is BIONANO GENOMICS INC (BNGO) expected to grow?

The Revenue of BIONANO GENOMICS INC (BNGO) is expected to decline by -0.27% in the next year. Check the estimates tab for more information on the BNGO EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy BIONANO GENOMICS INC (BNGO) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BIONANO GENOMICS INC (BNGO) stock pay dividends?

BNGO does not pay a dividend.


When does BIONANO GENOMICS INC (BNGO) report earnings?

BIONANO GENOMICS INC (BNGO) will report earnings on 2025-11-11, after the market close.


What is the Price/Earnings (PE) ratio of BIONANO GENOMICS INC (BNGO)?

BIONANO GENOMICS INC (BNGO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-42.97).


What is the Short Interest ratio of BIONANO GENOMICS INC (BNGO) stock?

The outstanding short interest for BIONANO GENOMICS INC (BNGO) is 8.51% of its float. Check the ownership tab for more information on the BNGO short interest.


BNGO Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to BNGO. When comparing the yearly performance of all stocks, BNGO is a bad performer in the overall market: 95.41% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

BNGO Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to BNGO. Both the profitability and financial health of BNGO have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BNGO Financial Highlights

Over the last trailing twelve months BNGO reported a non-GAAP Earnings per Share(EPS) of -42.97. The EPS increased by 66.53% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -97.79%
ROE -163.82%
Debt/Equity 0.08
Chartmill High Growth Momentum
EPS Q2Q%84.92%
Sales Q2Q%-13.36%
EPS 1Y (TTM)66.53%
Revenue 1Y (TTM)-25.03%

BNGO Forecast & Estimates

9 analysts have analysed BNGO and the average price target is 9.69 USD. This implies a price increase of 149.74% is expected in the next year compared to the current price of 3.88.

For the next year, analysts expect an EPS growth of 91.12% and a revenue growth -0.27% for BNGO


Analysts
Analysts80
Price Target9.69 (149.74%)
EPS Next Y91.12%
Revenue Next Year-0.27%

BNGO Ownership

Ownership
Inst Owners10.32%
Ins Owners0.05%
Short Float %8.51%
Short Ratio3.37